Metastatic renal cell carcinoma: update on epidemiology, genetics, and therapeutic modalities

@inproceedings{Graves2013MetastaticRC,
  title={Metastatic renal cell carcinoma: update on epidemiology, genetics, and therapeutic modalities},
  author={A. S. Rev. Graves and Hannah Hessamodini and G. Dianna Wong and Wai H Lim},
  booktitle={ImmunoTargets and therapy},
  year={2013}
}
The treatment of advanced renal cell carcinoma (RCC) remains a major therapeutic challenge for clinicians. Despite advances in the understanding of the immunobiology of RCC and the availability of several novel targeted agents, there has been little improvement in the survival of patients with metastatic RCC. This review will focus on the recent understanding of risk factors and treatment options and outcomes of metastatic RCC, in particular, targeted therapeutic agents that inhibit vascular… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 12 CITATIONS

CLINICAL CASE OF THE MONTH A 52-Year-Old Man with Back Pain

Caroline Davidson, Samantha Karlin, +6 authors Fred A. Lopez
  • 2018

References

Publications referenced by this paper.
SHOWING 1-10 OF 145 REFERENCES

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.

  • The New England journal of medicine
  • 2012
VIEW 20 EXCERPTS
HIGHLY INFLUENTIAL

Epidemiology and risk factors for kidney cancer

Wong-Ho Chow, Linda M. Dong, Susan S. Devesa
  • Nature Reviews Urology
  • 2010
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Immunotherapy for Renal Cell Carcinoma

  • Clinical & developmental immunology
  • 2010
VIEW 21 EXCERPTS
HIGHLY INFLUENTIAL

Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2010
VIEW 20 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…